COVID-19 status quo: Emphasis on gastrointestinal and liver manifestations

Table 3 Liver manifestations in coronavirus disease 2019

Ref.	Number of subjects	Abnormal LFTs (any)	ALT	AST	Tbili
Lin et al[35], 2020	95	-	5%	4%	23%
Wang et al[38], 2020	105	56%	16%	9%	2%
Fan et al[39], 2020	148	37%	18%	22%	6%
Zhang et al[63], 2020	1628	14%-53%	-	-	-
Cai et al[65], 2020	417	76%	-	-	-
Sultan et al[60], 2020	10890	-	15%	15%	17%

AST: Aspartate aminotransferase; ALT: Alanine aminotransferase.